Resultats de la cerca - Nicholas Cullen
- Mostrar 1 - 20 resultats de 29
- Anar a la pàgina següent
-
1
-
2
-
3
Peroneal tendon disorders per Kinner Davda, Karan Malhotra, Paul O’Donnell, Dishan Singh, Nicholas Cullen
Publicat 2017Revisão -
4
-
5
-
6
Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia per Eske Christiane Gertje, Shorena Janelidze, Danielle van Westen, Nicholas Cullen, Erik Stomrud, Sebastian Palmqvist, Oskar Hansson, Niklas Mattsson
Publicat 2023Artigo -
7
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease per Hlin Kvartsberg, Tammaryn Lashley, Christina E. Murray, Gunnar Brinkmalm, Nicholas Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Erik Portelius
Publicat 2018Artigo -
8
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations per Nicholas Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson, Oskar Hansson
Publicat 2021Artigo -
9
-
10
Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures per Sebastian Palmqvist, Pontus Tideman, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, Jeffrey L. Dage, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Oskar Hansson
Publicat 2021Artigo -
11
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance per Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson, Oskar Hansson
Publicat 2022Artigo -
12
Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controll... per Nicholas Cullen, Petr Novák, Duygu Tosun, Branislav Kováčech, Jozef Hanes, Eva Kontseková, Michal Fresser, Stefan Ropele, Howard Feldman, Reinhold Schmidt, Bengt Winblad, Norbert Žilka
Publicat 2023Artigo -
13
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease per Niklas Mattsson, Shorena Janelidze, Sebastian Palmqvist, Nicholas Cullen, Anna L. Svenningsson, Olof Strandberg, David Mengel, Dominic M. Walsh, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson
Publicat 2020Artigo -
14
Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models per Nicholas Cullen, Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Tobias Bittner, Ivonne Suridjan, Alexander Jethwa, Gwendlyn Kollmorgen, Wagner S. Brum, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Oskar Hansson
Publicat 2022Artigo -
15
Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes per Antoine Leuzy, Niklas Mattsson, Nicholas Cullen, Erik Stomrud, Sebastian Palmqvist, Renaud La Joie, Leonardo Iaccarino, Henrik Zetterberg, Gil D. Rabinovici, Kaj Blennow, Shorena Janelidze, Oskar Hansson
Publicat 2023Artigo -
16
Convolutional Neural Networks with Template-Based Data Augmentation for Functional Lung Image Quantification per Nicholas J. Tustison, Brian Avants, Zixuan Lin, Xue Feng, Nicholas Cullen, Jaime F. Mata, Lucía Flors, James C. Gee, Talissa A. Altes, John P. Mugler, Kun Qing
Publicat 2018Artigo -
17
Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients per Ruben Smith, Nicholas Cullen, Alexa Pichet Binette, Antoine Leuzy, Kaj Blennow, Henrik Zetterberg, Gregory Klein, Edilio Borroni, Rik Ossenkoppele, Shorena Janelidze, Sebastian Palmqvist, Niklas Mattsson, Erik Stomrud, Oskar Hansson
Publicat 2022Artigo -
18
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease per Claudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren, Erik Portelius, Johan Gobom, Nicholas Cullen, Oskar Hansson, Lucilla Parnetti, Radu Constantinescu, Kristin R. Wildsmith, Hsu-Hsin Chen, Thomas G. Beach, Tammaryn Lashley, Henrik Zetterberg, Kaj Blennow, Kina Höglund
Publicat 2018Artigo -
19
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A mul... per Gemma Salvadó, Victoria Larsson, Karly Alex Cody, Nicholas Cullen, Erin M. Jonaitis, Erik Stomrud, Gwendlyn Kollmorgen, Norbert Wild, Sebastian Palmqvist, Shorena Janelidze, Niklas Mattsson, Henrik Zetterberg, Kaj Blennow, Sterling C. Johnson, Rik Ossenkoppele, Oskar Hansson
Publicat 2023Artigo -
20
The ANTsX ecosystem for quantitative biological and medical imaging per Nicholas J. Tustison, Philip A. Cook, Andrew J. Holbrook, Hans J. Johnson, John Muschelli, Gabriel A. Devenyi, Jeffrey Duda, Sandhitsu R. Das, Nicholas Cullen, Daniel L. Gillen, Michael A. Yassa, James R. Stone, James C. Gee, Brian Avants
Publicat 2021Artigo
Eines de cerca:
Matèries relacionades
Medicine
Disease
Internal medicine
Alzheimer's disease
Dementia
Pathology
Oncology
Psychology
Biomarker
Cerebrospinal fluid
Cognitive decline
Psychiatry
Biochemistry
Biology
Cognition
Computer science
Neuroscience
Nuclear medicine
Neurodegeneration
Positron emission tomography
Cognitive impairment
Radiology
Alzheimer's Disease Neuroimaging Initiative
Ankle
Artificial intelligence
Chemistry
Database
Magnetic resonance imaging
Neuroimaging
Surgery